RadioGraphics, Vol 18, 827-848, Copyright © 1998 by Radiological Society of North America

REVIEWS

Nonneoplastic liver disease: evaluation with CT and MR imaging

S Kawamoto, PA Soyer, EK Fishman and DA Bluemke
Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA.

A wide range of nontumorous hepatic diseases may have an impact on liver function and serve as indications for computed tomographic (CT) or magnetic resonance (MR) imaging. New imaging techniques such as spiral CT and fast MR imaging aid in detecting and characterizing these disease processes and in assessing the extent of disease. Infectious liver disease (eg, hepatic abscess, echinococcal disease, fungal infection) typically has low attenuation at CT and high signal intensity at T2-weighted MR imaging. Cholangitis is characterized by ductal dilatation at both CT and MR imaging. In acute portal vein thrombosis, the thrombus has low attenuation at CT and is hyperintense relative to liver at MR imaging. Hepatic infarcts usually appear as well-circumscribed, peripheral, wedge-shaped areas of decreased attenuation at CT. The causes or complications of cirrhosis can be most readily identified with MR imaging. In patients with chronic radiation- induced hepatitis, CT shows the irradiated parenchyma as a region of increased attenuation, whereas T1- and T2-weighted MR imaging demonstrate geographic areas of low and high signal intensity, respectively. Hemachromatosis has homogeneously increased liver attenuation at CT and decreased signal intensity at gradient-echo MR imaging in particular. Familiarity with the CT and MR imaging features of the spectrum of nonneoplastic conditions of the liver is essential in making an accurate diagnosis.

This article has been cited by other articles:

				D. C. Rivard and L. H. Lowe Radiological Reasoning: Multiple Hepatic Masses in an Infant Am. J. Roentgenol., June 1, 2008; 190(6_Supplement): S46 - S52. [Full Text] [PDF]

				C.-H. Liu, D. C. Rivard, A. C. Silva, K. J. Burkholz, and S. D. Beaty Imaging of Focal Hepatic Lesions: Self-Assessment Module Am. J. Roentgenol., June 1, 2008; 190(6_Supplement): S65 - S68. [Abstract] [Full Text] [PDF]

				B. G. Stewart, D. A. Gervais, M. J. O'Neill, G. W. Boland, P. F. Hahn, and P. R. Mueller Imaging and Percutaneous Treatment of Secondarily Infected Hepatic Infarctions Am. J. Roentgenol., March 1, 2008; 190(3): 601 - 607. [Abstract] [Full Text] [PDF]

				R. Nomura, Y. Ishizaki, K. Suzuki, and S. Kawasaki Development of Hepatic Steatosis After Pancreatoduodenectomy Am. J. Roentgenol., December 1, 2007; 189(6): 1484 - 1488. [Abstract] [Full Text] [PDF]

				R. Garcia-Eulate, N. Hussain, T. Heller, D. Kleiner, H. Malech, S. Holland, and P. L. Choyke CT and MRI of hepatic abscess in patients with chronic granulomatous disease. Am. J. Roentgenol., August 1, 2006; 187(2): 482 - 490. [Abstract] [Full Text] [PDF]

				R. F. Munden, J. J. Erasmus, W. R. Smythe, J. E. Madewell, K. M. Forster, and C. W. Stevens Radiation Injury to the Liver After Intensity-Modulated Radiation Therapy in Patients with Mesothelioma: An Unusual CT Appearance Am. J. Roentgenol., April 1, 2005; 184(4): 1091 - 1095. [Abstract] [Full Text] [PDF]

				M. Nishino, K. Hayakawa, Y. Nakamura, T. Morimoto, and S. Mukaihara Effects of Tamoxifen on Hepatic Fat Content and the Development of Hepatic Steatosis in Patients with Breast Cancer: High Frequency of Involvement and Rapid Reversal After Completion of Tamoxifen Therapy Am. J. Roentgenol., January 1, 2003; 180(1): 129 - 134. [Abstract] [Full Text] [PDF]

				T. Gabata, M. Kadoya, O. Matsui, T. Kobayashi, Y. Kawamori, J. Sanada, N. Terayama, and S. Kobayashi Dynamic CT of Hepatic Abscesses: Significance of Transient Segmental Enhancement Am. J. Roentgenol., March 1, 2001; 176(3): 675 - 679. [Abstract] [Full Text] [PDF]